Oncolix to start trading on OTCQB
Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Oncolix, Inc. received OTC Markets' approval to be listed and traded on the OTCQB, effective Dec. 19.
The company had earlier changed its name to Oncolix from Advanced Environmental Petroleum Producers Inc.
With the listing, the company will now able to shift focus towards advancing its potential ovarian cancer treatment Prolanta, said CEO Michael Redman.
